| 摘要 |
The present invention provides stabilized amorphous lorcaserin hydrochloride (( R )-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]-azepine hydrochloride), a pharmaceutical composition comprising the same, as well as a process for obtaining the same. |
